BRUSSELS — Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion ​bid for Tylenol maker Kenvue, a filing ‌on the European Commission website showed on Wednesday. The European Commission, which acts as the EU competition ​enforcer, did not provide details of ​the remedies in line with its policy. ⁠It extended its deadline for a decision ​to October 13 from September 29. It is ​expected to seek feedback from rivals and customers before deciding whether to accept the concessions, demand more or ​open a full-scale four-month long investigation. The ​maker of Kleenex tissues and Huggies diapers is ready to ‌sell ⁠assets to address EU competition concerns that will likely help it secure approval at the end of regulators’ preliminary review. …Australian competition authorities ​cleared ⁠the deal earlier this month. …The U.S. ​company secured conditional approval in South Africa last month.